Form 8-K - Current report:
SEC Accession No. 0001104659-21-130731
Filing Date
2021-10-28
Accepted
2021-10-28 07:48:26
Documents
13
Period of Report
2021-10-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131101d1_8k.htm   iXBRL 8-K 31255
2 EXHIBIT 99.1 tm2131101d1_ex99-1.htm EX-99.1 71694
  Complete submission text file 0001104659-21-130731.txt   286359

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bpmc-20211028.xsd EX-101.SCH 3219
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpmc-20211028_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpmc-20211028_pre.xml EX-101.PRE 22733
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2131101d1_8k_htm.xml XML 3499
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 211355098
SIC: 2834 Pharmaceutical Preparations